Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Chiang Shen

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Drug Discovery Today|July 18, 2003
Oral peptide and protein delivery: unfulfilled promises?Wei-Chiang Shen
Idrugs : the Investigational Drugs Journal|December 23, 2003
Pulmonary drug deliveryWei-Chiang Shen
Pharmaceutical Research|September 5, 2006
Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimizationYun Bai, Wei-Chiang Shen
Botanical Studies|July 5, 2018
Nuclear dynamics in the homothallic ascomycete Sordaria fimicolaKulsumpun Krobanan, Wei-Chiang Shen
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 21, 2005
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugsChing-Jou Lim, Wei-Chiang Shen
Current Opinion in Molecular Therapeutics|June 16, 2006
Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancersLi-Jiuan Shen, Wei-Chiang Shen
Biochemical and Biophysical Research Communications|July 16, 2003
Quantitative comparison of membrane transduction and endocytosis of oligopeptidesJennica L Zaro, Wei-Chiang Shen
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 6, 2005
Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cellsJennica L Zaro, Wei-Chiang Shen
Pharmaceutical Research|December 14, 2004
Transferrin-oligomers as potential carriers in anticancer drug deliveryChing-Jou Lim, Wei-Chiang Shen
Experimental Cell Research|June 1, 2005
Evidence that membrane transduction of oligoarginine does not require vesicle formationJennica L Zaro, Wei-Chiang Shen
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Drug Discovery Today|July 18, 2003
Oral peptide and protein delivery: unfulfilled promises?Wei-Chiang Shen
Idrugs : the Investigational Drugs Journal|December 23, 2003
Pulmonary drug deliveryWei-Chiang Shen
Pharmaceutical Research|September 5, 2006
Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimizationYun Bai, Wei-Chiang Shen
Botanical Studies|July 5, 2018
Nuclear dynamics in the homothallic ascomycete Sordaria fimicolaKulsumpun Krobanan, Wei-Chiang Shen
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 21, 2005
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugsChing-Jou Lim, Wei-Chiang Shen
Current Opinion in Molecular Therapeutics|June 16, 2006
Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancersLi-Jiuan Shen, Wei-Chiang Shen
Biochemical and Biophysical Research Communications|July 16, 2003
Quantitative comparison of membrane transduction and endocytosis of oligopeptidesJennica L Zaro, Wei-Chiang Shen
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 6, 2005
Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cellsJennica L Zaro, Wei-Chiang Shen
Pharmaceutical Research|December 14, 2004
Transferrin-oligomers as potential carriers in anticancer drug deliveryChing-Jou Lim, Wei-Chiang Shen
Experimental Cell Research|June 1, 2005
Evidence that membrane transduction of oligoarginine does not require vesicle formationJennica L Zaro, Wei-Chiang Shen
Pageof 9